Uncategorized

CHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization

PTC Therapeutics, Inc. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ for the treatment of nonsense mutation Duchenne muscular dystrophy.

CHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization Read More »

Vampirismo humano

El vampirismo humano, un tema que ha perdurado a lo largo de la historia y la cultura popular, ha desconcertado a la ciencia y la sociedad durante mucho tiempo. A pesar de su origen en leyendas y mitos, ha habido casos documentados de personas que han exhibido comportamientos vampíricos. &nb …

Vampirismo humano Read More »

Scroll to Top